<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862088</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.985</article-id><article-id pub-id-type="other">EPV0234</article-id><article-id pub-id-type="pii">S0924933824009854</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Impact of addictive comorbidity on bipolar disorder type I</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Adouni</surname><given-names>A.</given-names></name><xref rid="aff2254" ref-type="aff"/><xref rid="cor0841" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zgueb</surname><given-names>Y.</given-names></name><xref rid="aff2254" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Ben Othman</surname><given-names>F.</given-names></name><xref rid="aff2254" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Bouguerra</surname><given-names>I.</given-names></name><xref rid="aff2254" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Jomli</surname><given-names>R.</given-names></name><xref rid="aff2254" ref-type="aff"/></contrib></contrib-group><aff id="aff2254">psychiatry department A, <institution>Razi hospital</institution>, <city>Manouba</city>, <country>Tunisia</country></aff><author-notes><corresp id="cor0841"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="960">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S475</fpage><lpage>S475</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824009854a.pdf"/><abstract><sec id="sec5058"><title>Introduction</title><p>Among all mental pathologies, bipolar disorder (BD) is the one in which addictive comorbidity is most frequent.</p><p>Recent studies suggest that this comorbidity has harmful consequences, threatening patients&#x02019; quality of life.</p></sec><sec id="sec5059"><title>Objectives</title><p>Describe addictive comorbidity and determine its prevalence in a population of patients with BD I.</p><p>Study the impact of addictive comorbidity on the evolution of BD I.</p></sec><sec id="sec5060"><title>Methods</title><p>A cross-sectional, comparative study was conducted over a six-month period in the after-care unit of psychiatric wards at Razi Hospital, including patients treated for BD I according to DSM 5 criteria and stable on treatment.</p><p>The study included two phases: first, sociodemographic, clinical and therapeutic characteristics were collected using a pre-established form. The CAGE, DUDIT and MARS scales, validated in Arabic, were then administered.</p></sec><sec id="sec5061"><title>Results</title><p>We included 100 patients (60 men and 40 women) with a mean age of 43.55 years.</p><p>Substance use disorder (SUD) was reported in 31% of our population; 22 alcohol users with a mean CAGE score of 1.23 (0-3), while psychoactive substance use was reported in 19 patients with a mean DUDIT score of 13.37 (0-28).</p><p>Forensic history was higher in the group of patients with comorbid SUD (p&#x0003c;0.001). Poor compliance with treatment and irregular follow-up were also significantly more associated with addictive behavior, respectively p=0.008 and p=0.048.</p><p>We found no association between SUD and suicidal behavior or evolutionary symptoms of the disorder.</p></sec><sec id="sec5062"><title>Conclusions</title><p>
SUD are generally factors in the poor prognosis of BD. It is important to identify the determinants of this comorbidity, so that these risk factors can be appropriately targeted through appropriate therapeutic interventions and thus limit these negative consequences.</p></sec><sec id="sec5063"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>